These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16510060)

  • 1. How should patients with Barrett's esophagus be monitored?
    Grover M; Strickland C; Kesler E; Crawford P
    J Fam Pract; 2006 Mar; 55(3):243-7. PubMed ID: 16510060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetic acid chromoendoscopy in Barrett's esophagus surveillance is superior to the standardized random biopsy protocol: results from a large cohort study (with video).
    Tholoor S; Bhattacharyya R; Tsagkournis O; Longcroft-Wheaton G; Bhandari P
    Gastrointest Endosc; 2014 Sep; 80(3):417-24. PubMed ID: 24713305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radio frequency ablation of Barrett's esophagus--can the risk of esophageal adenocarcinoma be reduced?].
    Salminen P; Räsänen J; Ristimäki A; Saarnio J; Heikkinen M; Laine S; Koivisto T; Färkkilä M
    Duodecim; 2014; 130(6):557-64. PubMed ID: 24724454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
    Wong T; Tian J; Nagar AB
    Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
    Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Barrett esophagus. Current situation of the risk and surveillance policy].
    Robaszkiewicz M
    Presse Med; 1994 Dec; 23(40):1846-8. PubMed ID: 7899314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Barrett's esophageal adenocarcinoma].
    Nakamura T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):322-6. PubMed ID: 15045933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A guide for surveillance of patients with Barrett's esophagus.
    Provenzale D; Kemp JA; Arora S; Wong JB
    Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of advanced endoscopic imaging on Barrett's esophagus in daily clinical practice.
    Beg S; Mensa M; Fullard M; Finerty E; Richman P; Leahy A
    Gastrointest Endosc; 2018 May; 87(5):1189-1194. PubMed ID: 28958906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endoscopic diagnosis of Barrett's adenocarcinoma].
    Yoshio H; Takashi Y; Mitsuyo H; Nobuhiko Y; Tatsurou T; Kazuhiko S; Yoko H; Shigemasa I; Hisanaga M; Osamu H; Katsuyoshi S; Seishi U; Matsushita H; Masahiko T
    Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):244-8. PubMed ID: 10379534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
    Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
    Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?
    Gorrepati VS; Sharma P
    Dig Dis Sci; 2018 Aug; 63(8):2115-2121. PubMed ID: 29675664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Bresalier RS
    Dig Dis Sci; 2018 Aug; 63(8):2155-2162. PubMed ID: 29948566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.